Covidien gets approval for generic pain drug Actiq
Covidien says FDA approved its version of Actiq, a powerful drug used against cancer pain
- On 4:45 pm EDT, Friday October 30, 2009
NEW YORK (AP) -- Covidien PLC said Friday it expects to start selling a generic version of the painkiller Actiq in early 2010.
Covidien's generic received Food and Drug Administration marketing on Friday. Covidien expects to start selling six different doses of generic Actiq, or fentanyl citrate, which is a powerful and addictive painkiller. It is approved only for use by cancer patients who are suffering from severe pain that is not being helped by other drugs.
Actiq is given in lollipop form. The branded version of Actiq is made by Cephalon Inc.
Barr Pharmaceuticals, a unit of Teva Pharmaceutical Industries, has marketed a generic version of Actiq since 2006.
Related Headlines
- Covidien to Present at Piper Jaffray Health Care Conference - Business Wire
- Cephalon upgraded by Jefferies & Co - Briefing.com
- CEPHALON INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E - EDGAR Online
- Early-Market Movers: Origin Agritech Limited, Ciena Corp - at Fox Business
- Drug stocks advance; Cephalon falls on study - at MarketWatch
Related Blog Headlines
- Cephalon Settles Barr Challenge - Zacks.com
- Monday Options Recap - at Seeking Alpha
- Nov. 23: Unusual Volume Leaders - at CNBC
- Biotech Stocks for a Possible Year-End Rally - at Seeking Alpha
- Covidien Rises on Improved '10 View - at Barrons.com
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale.
-
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today. -
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month.
Tech Ticker Recent Posts
- Are We Really Better Off Than We Were a Year Ago? - Peter Gorenstein
- Dollar Slumps After Fed Talks Turkey: Can Stocks Keep Up with Gold? - Aaron Task
- Don't Blame the Shorts: A History of Misplaced Aggression - Heesun Wee
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.